Pulmonary hypertension related to left-sided cardiac pathology

Pulmonary Medicine

Volumn , Issue , 2011, Pages

  Kiefer, Todd L ^a   Bashore, Thomas M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA VALVE DISEASE; AORTA VALVE STENOSIS; DIASTOLIC DYSFUNCTION; DISEASE ASSOCIATION; EPIDEMIC; HEART DISEASE; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE PRESSURE; HUMAN; LUNG ARTERY PRESSURE; MITRAL VALVE DISEASE; MORBIDITY; MORTALITY; PATHOGENESIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; PULMONARY VENO-OCCLUSIVE DISEASE; REVIEW; SYSTOLIC DYSFUNCTION;

EID: 84861605347     PISSN: 20901836     EISSN: 20901844     Source Type: Journal    
DOI: 10.1155/2011/381787     Document Type: Review

References (70)

1. McLaughlin V. V., Archer S. L., Badesch D. B., Barst R. J., Farber H. W., Lindner J. R., Mathier M. A., McGoon M. D., Park M. H., Rosenson R. S., Rubin L. J., Tapson V. F., Varga J., ACCF/AHA 2009 expert consensus document on pulmonary hypertension. A report of the American College of Cardiology Foundation task force on expert consensus documents and the American Heart Association Developed in Collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association Journal of the American College of Cardiology 2009 53 17 1573 1619
2. Gali N., Hoeper M. M., Humbert M., Torbicki A., Vachiery J.-L., Barbera J. A., Beghetti M., Corris P., Gaine S., Gibbs J. S., Gomez-Sanchez M. A., Jondeau G., Klepetko W., Opitz C., Peacock A., Rubin L., Zellweger M., Simonneau G., Vahanian A., Auricchio A., Bax J., Ceconi C., Dean V., Filippatos G., Funck-Brentano C., Hobbs R., Kearney P., McDonagh T., McGregor K., Popescu B. A., Reiner Z., Sechtem U., Sirnes P. A., Tendera M., Vardas P., Widimsky P., Al Attar N., Andreotti F., Aschermann M., Asteggiano R., Benza R., Berger R., Bonnet D., Delcroix M., Howard L., Kitsiou A. N., Lang I., Maggioni A., Nielsen-Kudsk J. E., Park M., Perrone-Filardi P., Price S., Domenech M. T. S., Vonk-Noordegraaf A., Zamorano J. L., Guidelines for the diagnosis and treatment of pulmonary hypertension European Heart Journal 2009 30 20 2493 2537
3. Ghio S., Gavazzi A., Campana C., Inserra C., Klersy C., Sebastiani R., Arbustini E., Recusani F., Tavazzi L., Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure Journal of the American College of Cardiology 2001 37 1 183 188 (Pubitemid 32051736)
4. Grigioni F., Potena L., Gali N., Fallani F., Bigliardi M., Coccolo F., Magnani G., Manes A., Barbieri A., Fucili A., Magelli C., Branzi A., Prognostic implications of serial assessments of pulmonary hypertension in severe chronic heart failure Journal of Heart and Lung Transplantation 2006 25 10 1241 1246 (Pubitemid 44528289)
5. Lam C. S. P., Roger V. L., Rodeheffer R. J., Borlaug B. A., Enders F. T., Redfield M. M., Pulmonary hypertension in heart failure with preserved ejection fraction. A community-based study Journal of the American College of Cardiology 2009 53 13 1119 1126
6. Walls M. C., Cimino N., Bolling S. F., Bach D. S., Persistent pulmonary hypertension after mitral valve surgery: does surgical procedure affect outcome? The Journal of Heart Valve Disease 2008 17 1 1 9
7. Krasuski R. A., Warner J. J., Wang A., Harrison J. K., Tapson V. F., Bashore T. M., Inhaled nitric oxide selectively dilates pulmonary vasculature in adult patients with pulmonary hypertension, irrespective of etiology Journal of the American College of Cardiology 2000 36 7 2204 2211
8. Krasuski R. A., Wang A., Harrison J. K., Tapson V. F., Bashore T. M., The response to inhaled nitric oxide in patients with pulmonary artery hypertension is not masked by baseline vasodilator use American Heart Journal 2005 150 4 725 728 (Pubitemid 41396507)
9. Montani D., O'Callaghan D. S., Savale L., Jas X., Yaci A., Maitre S., Dorfmuller P., Sitbon O., Simonneau G., Humbert M., Pulmonary veno-occlusive disease: recent progress and current challenges Respiratory Medicine 2010 104 supplement 1 S23 S32
10. Palazzini M., Manes A., Pulmonary veno-occlusive disease misdiagnosed as idiopathic pulmonary arterial hypertension European Respiratory Review 2009 18 113 177 180
11. Montani D., Achouh L., Dorfmller P., Le Pavec J., Sztrymf B., Tchérakian C., Rabiller A., Haque R., Sitbon O., Jas X., Dartevelle P., Matre S., Capron F., Musset D., Simonneau G., Humbert M., Pulmonary veno-occlusive disease: clinical, functional, radiologic, and hemodynamic characteristics and outcome of 24 cases confirmed by histology Medicine 2008 87 4 220 233
12. Bonow R. O., Carabello B. A., Chatterjee K., de Leon Jr. A. C., Faxon D. P., Freed M. D., Gaasch W. H., Lytle B. W., Nishimura R. A., O'Gara P. T., O'Rourke R. A., Otto C. M., Shah P. M., Shanewise J. S., Nishimura R. A., Carabello B. A., Faxon D. P., Freed M. D., Lytle B. W., O'Gara P. T., O'Rourke R. A., 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Journal of the American College of Cardiology 2008 52 13 e1 e142
13. Feldman TaG W., Baim D. S., Profiles in valvular heart disease Grossman's Cardiac Catheterization, Angiography, and Intervention 2006 7th Philadelphia, Pa, USA Lippincott Williams Wilkins 637 638
14. Snopek G., Pogorzelska H., Rywik T. M., Browarek A., Janas J., Korewicki J., Usefulness of endothelin-1 concentration in capillary blood in patients with mitral stenosis as a predictor of regression of pulmonary hypertension after mitral valve replacement or valvuloplasty American Journal of Cardiology 2002 90 2 188 189 (Pubitemid 34775136)
15. Levine M. J., Weinstein J. S., Diver D. J., Berman A. D., Wyman R. M., Cunningham M. J., Safian R. D., Grossman W., McKay R. G., Progressive improvement in pulmonary vascular resistance after percutaneous mitral valvuloplasty Circulation 1989 79 5 1061 1067 (Pubitemid 19129188)
16. Ribeiro P. A., Zaibag M. A., Abdullah M., Pulmonary artery pressure and pulmonary vascular resistance before and after mitral balloon valvotomy in 100 patients with severe mitral valve stenosis American Heart Journal 1993 125 4 1110 1114 (Pubitemid 23117345)
17. Hung J. S., Chern M. S., Wu J. J., Fu M., Yeh K. H., Wu Y. C., Cherng W. J., Chua S., Lee C. B., Short- and long-term results of catheter balloon percutaneous transvenous mitral commissurotomy American Journal of Cardiology 1991 67 9 854 862
18. Dev V., Shrivastava S., Time course of changes in pulmonary vascular resistance and the mechanism of regression of pulmonary arterial hypertension after balloon mitral valvuloplasty American Journal of Cardiology 1991 67 5 439 442
19. Ward C., Hancock B. W., Extreme pulmonary hypertension caused by mitral valve disease. Natural history and results of surgery British Heart Journal 1975 37 1 74 78
20. Braunwald E., Braunwald N. S., Ross J. Jr., Morrow A. G., Effects of mitral-valve replacement on the pulmonary vascular dynamics of patients with pulmonary hypertension The New England Journal of Medicine 1965 273 509 514
21. Dalen J. E., Matloff J. M., Evans G. L., Hoppin F. G., Bhardwaj P., Harken D. E., Dexter L., Early reduction of pulmonary vascular resistance after mitral-valve replacement The New England Journal of Medicine 1967 277 8 387 394
22. Morgan J. J., Hemodynamics one year following mitral valve replacement The American Journal of Cardiology 1967 19 2 189 195
23. Zielinski T., Pogorzelska H., Rajecka A., Biedermavn A., Sliwinski M., Korewicki J., Pulmonary hemodynamics at rest and effort, 6 and 12 months after mitral valve replacement: a slow regression of effort pulmonary hypertension International Journal of Cardiology 1993 42 1 57 62 (Pubitemid 23359071)
24. Tempe D. K., Hasija S., Datt V., Tomar A. S., Virmani S., Banerjee A., Pande B., Evaluation and comparison of early hemodynamic changes after elective mitral valve replacement in patients with severe and mild pulmonary arterial hypertension Journal of Cardiothoracic and Vascular Anesthesia 2009 23 3 298 305
25. Fattouch K., Sbraga F., Bianco G., Speziale G., Gucciardo M., Sampognaro R., Ruvolo G., Inhaled prostacyclin, nitric oxide, and nitroprusside in pulmonary hypertension after mitral valve replacement Journal of Cardiac Surgery 2005 20 2 171 176 (Pubitemid 40460131)
26. Santini F., Casali G., Franchi G., Auriemma S., Lusini M., Barozzi L., Favaro A., Messina A., Mazzucco A., Hemodynamic effects of inhaled nitric oxide and phosphodiesterase inhibitor (dipyridamole) on secondary pulmonary hypertension following heart valve surgery in adults International Journal of Cardiology 2005 103 2 156 163 (Pubitemid 41096028)
27. Healy D. G., Veerasingam D., McHale J., Luke D., Successful perioperative utilisation on inhaled nitric oxide in mitral valve surgery Journal of Cardiovascular Surgery 2006 47 2 217 220
28. Yurtseven N., Karaca P., Uysal G., Ozkul V., Cimen S., Tuygun A. K., Yuksek A., Canik S., A comparison of the acute hemodynamic effects of inhaled nitroglycerin and iloprost in patients with pulmonary hypertension undergoing mitral valve surgery Annals of Thoracic and Cardiovascular Surgery 2006 12 5 319 323
29. Rex S., Schaelte G., Metzelder S., Flier S., De Waal E. E. C., Autschbach R., Rossaint R., Buhre W., Inhaled iloprost to control pulmonary artery hypertension in patients undergoing mitral valve surgery: a prospective, randomized-controlled trial Acta Anaesthesiologica Scandinavica 2008 52 1 65 72
30. McGoon M. D., Kane G. C., Pulmonary hypertension: diagnosis and management Mayo Clinic Proceedings 2009 84 2 191 207
31. Shah R. V., Semigran M. J., Pulmonary hypertension secondary to left ventricular systolic dysfunction: contemporary diagnosis and management Current Heart Failure Reports 2008 5 4 226 232
32. Elliott C. G., Palevsky H. I., Treatment with epoprostenol of pulmonary arterial hypertension following mitral valve replacement for mitral stenosis Thorax 2004 59 6 536 537 (Pubitemid 38797529)
33. Bomma C., Ventura H. O., Daniel G., Patel H., Adjunctive sildenafil for the treatment of pulmonary hypertension after mitral valve replacement Congestive Heart Failure 2006 12 6 347 348
34. Johnson L. W., Hapanowicz M. B., Buonanno C., Bowser M. A., Marvasti M. A., Parker F. B., Pulmonary hypertension in isolated aortic stenosis. Hemodynamic correlations and follow-up Journal of Thoracic and Cardiovascular Surgery 1988 95 4 603 607 (Pubitemid 18098524)
35. Silver K., Aurigemma G., Krendel S., Barry N., Ockene I., Alpert J., Pulmonary artery hypertension in severe aortic stenosis: incidence and mechanism American Heart Journal 1993 125 1 146 150 (Pubitemid 23021636)
36. Faggiano P., Antonini-Canterin F., Ribichini F., D'Aloia A., Ferrero V., Cervesato E., Pavan D., Burelli C., Nicolosi G., Pulmonary artery hypertension in adult patients with symptomatic valvular aortic stenosis American Journal of Cardiology 2000 85 2 204 208 (Pubitemid 30026103)
37. Casaclang-Verzosa G., Nkomo V. T., Sarano M. E., Malouf J. F., Miller F. A., Oh J. K., E/Ea is the major determinant of pulmonary artery pressure in moderate to severe aortic stenosis Journal of the American Society of Echocardiography 2008 21 7 824 827
38. Kapoor N., Varadarajan P., Pai R. G., Echocardiographic predictors of pulmonary hypertension in patients with severe aortic stenosis European Journal of Echocardiography 2008 9 1 31 33 (Pubitemid 351664800)
39. Malouf J. F., Enriquez-Sarano M., Pellikka P. A., Oh J. K., Bailey K. R., Chandrasekaran K., Mullany C. J., Tajik A. J., Severe pulmonary hypertension in patients with severe aortic valve stenosis: clinical profile and prognostic implications Journal of the American College of Cardiology 2002 40 4 789 795 (Pubitemid 34925628)
40. Pai R. G., Varadarajan P., Kapoor N., Bansal R. C., Aortic valve replacement improves survival in severe aortic stenosis associated with severe pulmonary hypertension Annals of Thoracic Surgery 2007 84 1 80 85 (Pubitemid 46921129)
41. Khandhar S., Varadarajan P., Turk R., Sampat U., Patel R., Kamath A., Pai R. G., Survival benefit of aortic valve replacement in patients with severe aortic regurgitation and pulmonary hypertension Annals of Thoracic Surgery 2009 88 3 752 756
42. Naidoo D. P., Mitha A. S., Vythilingum S., Chetty S., Pulmonary hypertension in aortic regurgitation: early surgical outcome Quarterly Journal of Medicine 1991 80 291 589 595
43. Shapiro B. P., McGoon M. D., Redfield M. M., Unexplained pulmonary hypertension in elderly patients Chest 2007 131 1 94 100 (Pubitemid 46122979)
44. Borlaug B. A., Nishimura R. A., Sorajja P., Lam C. S. P., Redfield M. M., Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction Circulation: Heart Failure 2010 3 5 588 595
45. Hunt S. A., Abraham W. T., Chin M. H., Feldman A. M., Francis G. S., Ganiats T. G., Jessup M., Konstam M. A., Mancini D. M., Michl K., Oates J. A., Rahko P. S., Silver M. A., Stevenson L. W., Yancy C. W., 2009 focused update incorporated Into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults. A report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines developed in collaboration with the International Society for Heart and Lung Transplantation Journal of the American College of Cardiology 2009 53 15 e1 e90
46. Evaluating the Effectiveness of Sildenafil at Improving Health Outcomes and Exercise Ability in People with Diastolic Heart Failure (The RELAX Study), 2010, http://clinicaltrials.gov/ct2/show/NCT00763867?term=relaxrank=00763861
47. Guglin M., Khan H., Pulmonary hypertension in heart failure Journal of Cardiac Failure 2010 16 6 461 474
48. Dini F. L., Nuti R., Barsotti L., Baldini U., Dell'Anna R., Micheli G., Doppler-derived mitral and pulmonary venous flow variables are predictors of pulmonary hypertension in dilated cardiomyopathy Echocardiography 2002 19 6 457 465 (Pubitemid 35026178)
49. Cody R. J., Haas G. J., Binkley P. F., Capers Q., Kelley R., Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure Circulation 1992 85 2 504 509
50. Wei C. M., Lerman A., Rodeheffer R. J., McGregor C. G. A., Brandt R. R., Wright S., Heublein D. M., Kao P. C., Edwards W. D., Burnett J. C., Endothelin in human congestive heart failure Circulation 1994 89 4 1580 1586 (Pubitemid 24114234)
51. Abramson S. V., Burke J. F., Kelly J. J., Kitchen J. G., Dougherty M. J., Yih D. F., McGeehin F. C., Shuck J. W., Phiambolis T. P., Pulmonary hypertension predicts mortality and morbidity in patients with dilated cardiomyopathy Annals of Internal Medicine 1992 116 11 888 895 (Pubitemid 23034779)
52. Cappola T. P., Felker G. M., Kao W. H. L., Hare J. M., Baughman K. L., Kasper E. K., Pulmonary hypertension and risk of death in cardiomyopathy: patients with myocarditis are at higher risk Circulation 2002 105 14 1663 1668 (Pubitemid 34298609)
53. Kjaergaard J., Akkan D., Iversen K. K., Kjoller E., Kber L., Torp-Pedersen C., Hassager C., Prognostic importance of pulmonary hypertension in patients with heart failure American Journal of Cardiology 2007 99 8 1146 1150 (Pubitemid 46578202)
54. Delgado J. F., Gomez-Sanchez M. A., Saenz de la Calzada C., Impact of mild pulmonary hypertension on mortality and pulmonary artery pressure profile after heart transplantation Journal of Heart and Lung Transplantation 2001 20 9 942 948 (Pubitemid 32824139)
55. Mehra M. R., Kobashigawa J., Starling R., Russell S., Uber P. A., Parameshwar J., Mohacsi P., Augustine S., Aaronson K., Barr M., Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates-2006 Journal of Heart and Lung Transplantation 2006 25 9 1024 1042 (Pubitemid 44311532)
56. Costard-Jackle A., Fowler M. B., Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group Journal of the American College of Cardiology 1992 19 1 48 54
57. Zakliczynski M., Maruszewski M., Pyka L., Trybunia D., Nadziakiewicz P., Przybylski R., Zembala M., Effectiveness and safety of treatment with sildenafil for secondary pulmonary hypertension in heart transplant candidates Transplantation Proceedings 2007 39 9 2856 2858 (Pubitemid 350088099)
58. Martin J., Siegenthaler M. P., Friesewinkel O., Fader T., Van De Loo A., Trummer G., Berchtold-Herz M., Beyersdorf F., Implantable left ventricular assist device for treatment of pulmonary hypertension in candidates for orthotopic heart transplantationa preliminary study European Journal of Cardio-Thoracic Surgery 2004 25 6 971 977 (Pubitemid 38622337)
59. Salzberg S. P., Lachat M. L., von Harbou K., Znd G., Turina M. I., Normalization of high pulmonary vascular resistance with LVAD support in heart transplantation candidates European Journal of Cardio-Thoracic Surgery 2005 27 2 222 225 (Pubitemid 40193130)
60. Liden H., Haraldsson A., Ricksten S.-E., Kjellman U., Wiklund L., Does pretransplant left ventricular assist device therapy improve results after heart transplantation in patients with elevated pulmonary vascular resistance? European Journal of Cardio-Thoracic Surgery 2009 35 6 1029 1035
61. Alba A. C., Rao V., Ross H. J., Jensen A. S., Sander K., Gustafsson F., Delgado D. H., Impact of fixed pulmonary hypertension on post-heart transplant outcomes in bridge-to-transplant patients Journal of Heart and Lung Transplantation 2010 29 11 1253 1258
62. Mikus E., Stepanenko A., Krabatsch T., Loforte A., Dandel M., Lehmkuhl H. B., Hetzer R., Potapov E. V., Reversibility of fixed pulmonary hypertension in left ventricular assist device support recipients. European Journal of Cardio-thoracic Surgery. In Press
63. John R., Liao K., Kamdar F., Eckman P., Boyle A., Colvin-Adams M., Effects on pre- and posttransplant pulmonary hemodynamics in patients with continuous-flow left ventricular assist devices Journal of Thoracic and Cardiovascular Surgery 2010 140 2 447 452
64. Califf R. M., Adams K. F., McKenna W. J., Gheorghiade M., Uretsky B. F., McNulty S. E., Darius H., Schulman K., Zannad F., Handberg-Thurmond E., Harrell F. E., Wheeler W., Soler-Soler J., Swedberg K., A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: the Flolan International Randomized Survival Trial (FIRST) American Heart Journal 1997 134 1 44 54 (Pubitemid 27329022)
65. Anand P. I., McMurray P. J., Cohn P. J. N., Konstam P. M. A., Notter T., Quitzau K., Ruschitzka F., Lscher P. T. F., Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the EndothelinA Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial The Lancet 2004 364 9431 347 354 (Pubitemid 38970011)
66. Packer M., McMurray J., Massie B. M., Caspi A., Charlon V., Cohen-Solal A., Kiowski W., Kostuk W., Krum H., Levine B., Rizzon P., Soler J., Swedberg K., Anderson S., Demets D. L., Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot study Journal of Cardiac Failure 2005 11 1 12 20 (Pubitemid 40215308)
67. Colucci W. S., Elkayam U., Horton D. P., Abraham W. T., Bourge R. C., Johnson A. D., Wagoner L. E., Givertz M. M., Liang C.-S., Neibaur M., Haucht W. H., Lejemtel T. H., Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure The New England Journal of Medicine 2000 343 4 246 253 (Pubitemid 30490392)
68. Mehra M. R., Ventura H. O., Kapoor C., Stapleton D. D., Zimmerman D., Smart F. W., Safety and clinical utility of long-term intravenous milrinone in advanced heart failure American Journal of Cardiology 1997 80 1 61 64 (Pubitemid 27274580)
69. Lewis G. D., Shah R., Shahzad K., Camuso J. M., Pappagianopoulos P. P., Hung J., Tawakol A., Gerszten R. E., Systrom D. M., Bloch K. D., Semigran M. J., Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension Circulation 2007 116 14 1555 1562 (Pubitemid 47511419)
70. Guazzi M., Samaja M., Arena R., Vicenzi M., Guazzi M. D., Long-term use of sildenafil in the therapeutic management of heart failure Journal of the American College of Cardiology 2007 50 22 2136 2144 (Pubitemid 350117342)